Biologically Active Heterocyclic Compounds
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 98893
Special Issue Editor
Interests: biologically active heterocycles; thiazole; thiazolidinone; benzothiazole; thiadiazoles with antimicrobial activity; COX/LOX, PTP1b, HIV RT enzyme inhibitors; anti inflammatory; carbonic anhydrase; DPP4; cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Heterocyclic compounds are attractive targets for medicinal chemists.
Many heterocyclic scaffolds can be considered as privilege structures. Most recurrently, nitrogen heterocycles or various positional combinations of nitrogen atoms, sulfur, and oxygen in five- or six-membered rings can be found. According to statistics, more than 85% of all biologically-active chemical entities contain a heterocycle. Five membered heterocycles with two or three heteroatoms, such as thiazoles, benzo-thiazoles, thiazolidinones, triazoles, and others, are key structural units in many pharmaceutical preparations.
Thus, many synthetic pyrazoles are very important medicinals, such as fever-reducing analgesic aminopyrine and anti-inflammatory drug phenylbutazone, used for arthritis treatment. Imidazoles are the most important heterocycle present in histamin, in hydantoin derivatives, especially in phenytoin, an important antiepileptic drug, as well as in biotin. The antibiotic cycloserine is one of the few naturally occurring isoxazoles.
Another interesting core of excessive biological activity is thiazole, which occurs in thiamin (vitamin B1), penicillin and bacitracin antibiotics. Furthermore, there are a lot of synthetic drugs bearing a thiazole ring. Among them are antimicrobial agents sulfathiazole and acinitrazole, the antidepressant pramipexole, the antiasthmatic drug cinalukas, and the anti-inflammatory meloxicam. A benzimidazole unit occurs in vitamin B12. Folic acid, a pteridine, is a B-complex vitamin and an important growth factor, while Riboflavin, or vitamin B2, is a derivative of alloxazine.
Biologically and pharmacologically, the pyrimidines are very important, including three of the five nucleotide bases that constitute the genetic code in DNA and RNA.
This fact echoes the central role of heterocycles in modern drug design.
The increasing presence of various heterocycles in drugs is related to advances in synthetic methodologies, allowing rapid access to a wide variety of functionalized heterocycles. On the other hand, many heterocyclic lead compounds were isolated from natural resources, and their structures were subsequently simplified and modified by medicinal chemists. Thus, heterocycles have critical importance for medicinal chemists, for the reason that, using them, it is possible to increase the available drug-like chemical space and drive more effective drug discovery programs.
Thus, the aim of the current Special Issue is to collect and present recent advances in the research fields connected to heterocyclic compounds of different types of activities, such as anticancer, anti-inflammatory, antioxidant, antimicrobial, antidiabetic, etc.
Prof. Dr. Athina Geronikaki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 5 member heterocyclic compounds
- 6 member heterocyclic compounds
- biological activity (antimicrobial, anti-inflammatory, anticancer and many others)
- molecular docking
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.